An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.

Saved in:
Bibliographic Details
Title: An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.
Authors: Tian, Meijie1, Cheuk, Adam T.1, Wei, Jun S.1, Abdelmaksoud, Abdalla1,2, Hsien-Chao Chou1, Milewski, David1, Kelly, Michael C.3, Song, Young K.1, Dower, Christopher M.4, Nan Li5, Haiying Qin6, Yong Yean Kim1, Wu, Jerry T.1, Xinyu Wen1, Benzaoui, Mehdi6, Masih, Katherine E.1,7, Xiaolin Wu8, Zhongmei Zhang9, Badr, Sherif9, Taylor, Naomi6
Source: Journal of Clinical Investigation. 8/15/2022, Vol. 132 Issue 16, p1-17. 17p.
Database: Academic Search Ultimate
Description
ISSN:00219738
DOI:10.1172/JCI155621